I may sound repetitive, but I will say it again.
“promising” and “exciting” are cheap words.
Don’t blame the credit crunch MR. Farjo. ICX PRO doesn’t work. You completed Phase III, and it didn’t work. The credit crunch has nothing to do with this.
That is why ICX sank to the depths.
Basically, ICX put all of its money to ICX.PRO. The other products in the pipeline were fancy products just for show, with no allocated resources, because all your hopes were with PRO.
If PRO, the most cherished product, didn’t work, its not difficult to imagine how poor Vavelta and TRC, and others, perform.
So I think, the failure lies on fundamental flaws of the scientific team’s ideas.
And the idea of creating protohairs is not new. Many years ago, other doctors were already promising “hairs on a petri dish”. And still nothing. Old hypes with new envelopes.
We have already paid too much attention to this company. Now its Dr. Washenik’s time. Lets see how it goes.
» from baldingblog.com
» Back in 2007 and early 2008, Intercytex genuinely believed that good news
» was around the corner. This was based on the very promising results of the
» laboratory work. What happened was that the positive results of clinical
» trials were not as efficient as the lab ones. In other words although
» promising and exciting, not quite good enough to justify applying for a
» therapeutic product for the public. Since then three things have happened.
» Firstly the credit crunch hit the biotech sector hard in that major
» investors pulled out. Secondly, an unrelated Intercytex product did not
» come up with the goods, which meant negatively affecting the company share
» price. Thirdly, money aside, Intercytex agreed that the future probably
» lies in their ongoing lab research of making fully formed hairs from the
» cloned cells before taking them back to the donor. At this point, I dont
» know when this work will result in a clinical trial.